UC Irvine AD Translational Center for Disease Model Resources-NextSeq Supplement
UC Irvine AD Translational Center for Disease Model Resources-NextSeq Supplement
批准号:
10320292
负责人:
FRANK M LAFERLA
金额:
$9.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2022-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
A key goal of the UCI Model-AD Disease Model Development and Phenotyping Project (DMDPP) is to
characterize the gene expression levels of the new rodent models of sporadic AD being generated by the
consortium during aging. This involves the building of numerous bulk and single-cell RNA-seq libraries for Model-
AD mice. All of these libraries are currently sequenced on an Illumina NextSeq 500 purchased in 2013. As this
instrument is nearing its end-of-life support by Illumina, we are requesting funds to upgrade the Illumina NextSeq
2000 system in order to increase the reliability and throughput of sequencing the bulk and single-cell RNA-seq
libraries produced by UCI Model-AD. The upgrade will ensure the timely sequencing of the RNA-seq libraries for
the characterization of the changes of gene expression during aging in the UCI model-AD rodent models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
-
批准号:10463741
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2021
-
负责人:FRANK M LAFERLA
-
依托单位:
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
-
批准号:10636861
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2021
-
负责人:FRANK M LAFERLA
-
依托单位:
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
-
批准号:10280235
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2021
-
负责人:FRANK M LAFERLA
-
依托单位:
Core A-Administrative Core
-
批准号:9922100
-
项目类别:
-
资助金额:$40.8万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
The Alzheimer's Disease Research Center at the University of California, Irvine
-
批准号:10582616
-
项目类别:
-
资助金额:$288.48万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
Core A-Administrative Core
-
批准号:10378027
-
项目类别:
-
资助金额:$45.22万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
Core A-Administrative Core
-
批准号:10188381
-
项目类别:
-
资助金额:$71.9万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
The Alzheimer's Disease Research Center at the University of California, Irvine
-
批准号:10774385
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
The Alzheimer's Disease Research Center at the University of California, Irvine
-
批准号:10747262
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
The Alzheimer's Disease Research Center at the University of California, Irvine
-
批准号:9922099
-
项目类别:
-
资助金额:$288.37万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
The Alzheimer's Disease Research Center at the University of California, Irvine
-
批准号:10188380
-
项目类别:
-
资助金额:$288.48万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
The Alzheimer's Disease Research Center at the University of California, Irvine
-
批准号:10378026
-
项目类别:
-
资助金额:$288.48万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
NF-κB as a driver of neurotoxic astrocytes in Alzheimers disease
-
批准号:10055202
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
Core A-Administrative Core
-
批准号:10582617
-
项目类别:
-
资助金额:$49.87万
-
财政年份:2020
-
负责人:FRANK M LAFERLA
-
依托单位:
UC Irvine AD Translational Center for Disease Model Resources-Spatial Transcriptomics Supplement
-
批准号:10358060
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2017
-
负责人:FRANK M LAFERLA
-
依托单位:
UC Irvine AD Translational Center for Disease Model Resources
-
批准号:9562018
-
项目类别:
-
资助金额:$222.83万
-
财政年份:2017
-
负责人:FRANK M LAFERLA
-
依托单位:
UC Irvine AD Translational Center for Disease Model Resources
-
批准号:10250340
-
项目类别:
-
资助金额:$280.32万
-
财政年份:2017
-
负责人:FRANK M LAFERLA
-
依托单位:
UC Irvine AD Translational Center for Disease Model Resources-Microbiome Supplement
-
批准号:9932650
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2017
-
负责人:FRANK M LAFERLA
-
依托单位:
Admin/Coordination Core
-
批准号:10708161
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2017
-
负责人:FRANK M LAFERLA
-
依托单位:
Administrative/Coordination Core
-
批准号:10250341
-
项目类别:
-
资助金额:$20.57万
-
财政年份:2017
-
负责人:FRANK M LAFERLA
-
依托单位: